Here, we report that gastric cancers with a mesenchymal phenotype are associated with poor prognosis, markedly low somatic mutation rates and microsatellite instability (MSI), resistance to standard chemotherapy, and sensitive to inhibition of IGF1/IGF1R pathway. The gene discussed is IGF1; the disease is gastric cancer.